Edition:
United Kingdom

People: Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.26
Open
$1.17
Day's High
$1.26
Day's Low
$1.17
Volume
40,776
Avg. Vol
64,280
52-wk High
$2.05
52-wk Low
$0.75

Ostrowski, Mark 

Mr. Mark Ostrowski has been appointed as President of Phenogen Sciences Inc., the subsidiary of Genetic Technologies Ltd., effect from 25 November 2014. Mr. Ostrowski joined the Company in September 2012, and was appointed to the position of Senior VP Sales and Marketing. Mr Ostrowski possesses over 20 years of sales and marketing experience in molecular diagnostics having served in senior managerial positions at companies focused on women’s. health and oncology, including as Director of Sales Operations at Myriad Genetics (NASDAQ: MYGN) and Director of Managed Care Services at DIANON Systems (NASDAQ: DIAN). Prior to joining the Company, Mr. Ostrowski’s career spanned both early stage and established biomedical companies. During his tenure at Myriad, he had comprehensive exposure to all aspects of sales and marketing, managing a sales force of over 200 representatives, demonstrating average annual revenue growth of over 50%, and generating new strategic divisions and best practice policies.

Basic Compensation

Total Annual Compensation, USD 232,731
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 63,549
Fiscal Year Total, USD 296,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --